Elessar maintains close relationships with leading biotech and pharmaceutical companies across the global innovation ecosystem, providing early access to differentiated therapeutic assets, emerging AI-native platforms, and cross-border strategic opportunities.

Building on this network, Elessar actively seeks collaborations with leading biotech companies, innovative AI-driven therapeutic platforms, and computational drug discovery teams worldwide.